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Abstract The bacterial protein RelE severely restricts prokar-
yotic cell growth, probably by acting as a global inhibitor of
translation. It is ubiquitous in prokaryotes as part of the RelE^
RelB toxin^antitoxin system, and may be activated by nutri-
tional stress. When the relE gene from Escherichia coli was
expressed inducibly in a human osteosarcoma cell line, it was
shown to retard growth and to lead to cell death by apoptosis.
RelE is therefore unusual among bacterial toxins in possessing
broad activity against both prokaryotes and eukaryotes, perhaps
by acting on evolutionarily conserved components of the
translation machinery. $ 2002 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
The Escherichia coli K-12 relBEF operon encodes three
proteins: RelE and RelB comprise a toxin^antitoxin module
[1,2], while RelF is a member of the Hok cytotoxin family [3].
RelE is an 11.2 kDa basic protein and is cytotoxic or cyto-
static when overexpressed in bacteria [2] due to a marked
inhibition of translation [4], which is probably mediated by
a direct interaction with ribosomes [5]. RelB is a 9.1 kDa
acidic protein which forms a strong complex with, and acts
to neutralise, RelE; it is relatively unstable, being susceptible
to Lon protease activity, and is also an autorepressor of the
relBEF operon [2,4]. The precise function of RelE^RelB is
unclear: when located on plasmids it may act as a stabilisa-
tion system by post-segregational killing [2,6], but the pres-
ence of relBE genes on the chromosomes of many bacterial
species, both eubacterial and archaeal [7], is inconsistent with
this. More recently, the RelE^RelB module has been proposed
to function as a stress response element, being activated by
amino acid starvation and serving to downregulate transla-
tional activity within the cell [4].
Prokaryotic protein toxins which act on bacteria are not
normally known to a¡ect eukaryotic cell types, but some evi-
dence suggests that RelE might also inhibit growth of the
yeast Saccharomyces cerevisiae [8]. This is a surprising ¢nding
since only one other protein of bacterial origin, Shiga toxin
(STX) and its relatives from Shigella dysenteriae, exerts toxic
e¡ects on both prokaryotic and eukaryotic cells [9]. To test
whether RelE is toxic in higher eukaryotes, the relE gene from
E. coli K-12 has been introduced under control of an induc-
ible promoter into the human osteosarcoma cell line U2OS. It
is shown that expression of the relE gene in human cells leads
to growth inhibition and cell death by apoptosis.
2. Materials and methods
2.1. Gene expression constructs
The E. coli K-12 relE gene was ampli¢ed by polymerase chain
reaction (PCR) from plasmid pBD2430 [10], using the oligonucleotide
primers ‘relE-5P’ (5P-GTCGACCATGGCGTATTTTCTGGATTT-
TG-3P) and ‘relE-3P’ (5P-GGTACCTCAGAGAATGCGTTTGACC-
G-3P), and its sequence con¢rmed after cloning in pCR2.1-TOPO
(Invitrogen, Groningen, The Netherlands) as pCR2.1-TOPO-relE.
The relE gene was excised as a PstI^BamHI (blunt-ended) fragment
and ligated in the sense orientation into expression vector pcDNA4/
TO (Invitrogen), digested with PstI^NotI (blunt-ended), giving plas-
mid pcDNA4/TO/relE. This was then modi¢ed by replacement of the
zeocin resistance gene with a cassette providing G418 resistance in
mammalian cells: a SpeI^NotI fragment from pCEP9L (a gift of
Mark Tykocinski, University of Pennsylvania School of Medicine)
was made blunt-ended using Klenow fragment, and this was ligated
to pcDNA4/TO/relE digested with PvuII, giving plasmid pcDNA4/
TO/relE(G418R). The relE gene was also inserted into pcDNA4/TO
in the antisense orientation from pCR2.1-TOPO-relE as a BamHI^
NotI fragment to give pcDNA4/TO/Eler. Constructs were con¢rmed
by restriction analysis and sequencing.
2.2. Cell lines and transfection
The human osteosarcoma TREx-U2OS cell line constitutively ex-
pressing tetracycline repressor from pcDNA6/TR (Invitrogen) was
routinely grown at 37‡C and 5% CO2 in Dulbecco’s modi¢ed Eagle’s
medium (DMEM) supplemented with 10% foetal calf serum, 10 mM
glutamine, 500 U/ml penicillin and 0.5 mg/ml streptomycin (Sigma-
Aldrich, Poole, UK). U2OS cells were transfected using GeneJammer
reagent (Stratagene, Amsterdam, The Netherlands) following manu-
facturer’s instructions. Brie£y, an 80% con£uent 35 mm dish with
900 Wl fresh serum containing DMEM was incubated for 3 h at
37‡C and 5% CO2 in the presence of 100 Wl DMEM, 6 Wl GeneJam-
mer reagent and 1 Wg DNA mixture after which an equal volume of
serum-containing DMEM was added. Cells were incubated at 37‡C
and 5% CO2 for an additional 24 h then split 1:5 into growth me-
dium. After a further 24 h transfectants were selected in growth
medium supplemented with 1 mg/ml G418 (Geneticin, Sigma-Aldrich)
or 250 Wg/ml zeocin (Invitrogen), depending on the construct used.
Multiple transfections were done in six-well plates for each construct,
selecting only one clone from each well. Transfectant clones generated
with pcDNA4/TO/relE(G418R) were designated U-relE; those con-
taining pcDNA4/TO/Eler were designated U-Eler.
2.3. Growth curve
U2OS transfectant clones were seeded atV5U104 cells each in T25
£asks. After 12 h incubation half of the £asks were induced with 5 Wg/
ml tetracycline and an equal volume of absolute ethanol added to the
other £asks as a control. Every 12 h for 72 h, starting from 0 h after
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induction, one induced £ask and one control £ask were washed with
phosphate-bu¡ered saline (PBS; pH 7.4), trypsinised and counted
with a haemocytometer (at least six counts per sample). Medium,
including tetracycline where appropriate, was replaced every 24 h in
£asks not being harvested.
2.4. MTT assay
Between 1U104 and 5U104 cells were seeded in each well of a six-
well (35 mm diameter) plate. After 12 h incubation at 37‡C wells were
treated with 5 Wg/ml tetracycline or absolute ethanol as a control.
Every 12 h for 72 h, starting from 0 h after induction, one induced
well and one control well were incubated with 5 mg/ml 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma-Al-
drich) for 6 h at 37‡C, then centrifuged at 2000 rpm for 10 min.
The medium was then aspirated o¡, 1 ml DMSO added, mechanically
mixed until crystals were dissolved and absorbance read in a micro-
culture plate reader at a test wavelength of 550 nm and a reference of
660 nm.
2.5. RT-PCR
For each clone, approximately 107 cells were harvested. The Abso-
lute RNA Miniprep Kit (Stratagene) was used to isolate total RNA;
mRNA was puri¢ed using PolyATtract Systems III and IV (Promega,
Southampton, UK), both according to manufacturer’s protocol. RT-
PCR was performed using the Access RT-PCR Kit (Promega) accord-
ing to manufacturer’s instructions using the relE-5P and relE-3P prim-
ers. Samples were taken from each PCR after 10, 20 and 30 cycles.
2.6. Cloning e⁄ciency
U-relE and U-Eler clones were plated at various densities (up to
107 cells per 15 cm dish) either with or without tetracycline induction
12 h after seeding. After incubation at 37‡C for a further 10 days,
medium was removed, plates were washed twice with PBS, stained
with Leichmann’s staining solution (eosin methylene blue; BDH
Merck, Poole, UK) for 3 h, rinsed gently in warm water and air-dried.
Colonies counted were related to number of cells seeded to calculate
cloning e⁄ciency.
2.7. DNA fragmentation analysis
Approximately 5U106 cells each were induced with 5 Wg/ml tetra-
cycline, an equal volume of absolute ethanol or 1 Wg/ml actinomycin
D (Sigma-Aldrich), 12 h after seeding. Floating cells were collected
every 12 h for 72 h, replacing fresh pre-warmed medium and the
appropriate amount of tetracycline, absolute ethanol or actinomycin
D each time, and stored at 320‡C until processing. The Suicide Track
DNA Ladder Isolation Kit (Oncogene Research Products/CN Bio-
sciences UK, Nottingham, UK) was used to isolate total DNA and
visualise samples according to manufacturer’s protocol.
3. Results
3.1. Growth curve and metabolic activity
To examine the e¡ect of RelE in human cells, the osteosar-
coma cell line U2OS was transfected with constructs contain-
ing the relE gene in the sense orientation, or, as a control, in
the antisense orientation, giving cell lines designated U-relE or
U-Eler, respectively. Gene expression was controlled by Tet
operator sequences in the promoter region, to which the con-
stitutively expressed Tet repressor protein binds; expression
was induced by addition of tetracycline. A typical growth
experiment for one U-relE clone and one U-Eler clone, with
or without tetracycline, is shown in Fig. 1.
The number of tetracycline-induced U-relE cells that adhere
to the £ask steadily decreased after 12 h, suggesting that relE
expression was detrimental to cell growth. In contrast, unin-
duced U-relE, and both induced and uninduced U-Eler cells,
maintained steady growth. Expression of the antisense relE
gene apparently has no e¡ect on growth. However, uninduced
U-relE cells grew at a slower rate than U-Eler cells, which was
attributed to a leaky promoter, and/or trace amounts of tet-
racycline present in the growth medium, giving rise to low
level expression of relE. Similar growth curves were obtained
when the experiment was repeated, and when other, indepen-
dent U-relE and U-Eler clones were used.
The e¡ect of relE expression on the metabolic status of the
cell was tested using the MTT assay, which measures activity
of mitochondrial dehydrogenases. A pattern similar to that
obtained from the growth curves was revealed (Fig. 2): meta-
bolic activity of tetracyline-treated U-relE cells declined after
12 h, whereas activity of uninduced U-relE cells, and both
induced and uninduced U-Eler cells, increased steadily, re£ect-
ing cell growth. The e¡ect of relE expression on the metabo-
lism of mammalian osteosarcoma cells is clearly inhibitory.
3.2. Transcription of relE sense and antisense genes
PCR analysis con¢rmed that the relE sense and antisense
constructs were intact in genomic DNA of their respective
transfectant cell clones (data not shown). Gene transcription
Fig. 1. Growth curve of U-relE and U-Eler with and without induc-
tion of sense and antisense relE. U-relE cells [(induced: ¢lled circle)
and (uninduced: ¢lled square)] were harvested every 12 h for 72 h
after induction and counted. U-Eler cells [(induced: ¢lled diamond)
and (uninduced: ¢lled triangle)] were processed in parallel. Vertical
bars indicate standard deviation.
Fig. 2. Metabolic activity in U-relE and U-Eler clones with and
without induction of sense and antisense relE. The MTT assay was
performed on tetracycline-treated (¢lled circles) and control U-relE
cells (¢lled squares) starting from 0 h after induction. Treated (¢lled
diamonds) and control U-Eler cells (¢lled triangles) were assayed in
parallel.
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was established by RT-PCR, with samples taken after 10, 20
and 30 cycles of PCR (Fig. 3). Tetracycline-induced U-relE
cells yielded a V350 bp RT-PCR product from 10 cycles of
the PCR, indicating relE transcription. In uninduced U-relE,
the same product was seen, but not until 30 cycles of PCR,
con¢rming the suggestion from Figs. 1 and 2 that the pro-
moter is leaky, giving basal level transcription even in the
absence of inducer. U-Eler cells showed a similar pattern of
expression of the antisense gene under control of the same
promoter and con¢rmed that antisense relE expression is
not detrimental.
3.3. RelE killing e⁄ciency
U-relE and U-Eler clones were plated at various densities
either with or without tetracycline induction. U-relE cells
failed to form colonies when relE expression was induced,
whereas uninduced U-relE and induced/uninduced U-Eler
cells showed approximately 50% plating e⁄ciency (data not
shown). The total number of cells plated was 2U108, suggest-
ing that, assuming 50% plating e⁄ciency without relE expres-
sion, less than 1 in 108 cells survive expression of the toxin
gene on induction. Intriguingly, the relatively low level of relE
expression observed in uninduced U-relE cells, which appar-
ently a¡ects growth, had little e¡ect on cloning e⁄ciency in
this experiment.
3.4. DNA fragmentation
When tetracycline-induced U-relE cells were visualised
under a light microscope, morphological changes including
membrane budding, chromatin condensation and fragmenta-
tion and reduction in cell volume were observed, all of which
are characteristic of apoptotic cell death [11]. Uninduced U-
relE and induced/uninduced U-Eler cells exhibited the normal
morphology of U2OS (results not shown). A typical ladder
pattern of DNA degradation, due to a caspase-activated
DNase, is also associated with apoptosis [12]. This was ob-
served in tetracycline-induced U-relE cells and was compara-
ble to apoptotic fragmentation induced by actinomycin D; the
e¡ect was not seen in uninduced cells. No fragmentation was
observed in tetracycline-treated or control U-Eler cells,
although actinomycin D was able to induce DNA degradation
(Fig. 4).
4. Discussion
When expressed in a human cell line, the E. coli K-12 relE
gene retards growth and results in cell death by apoptosis. In
bacteria, RelE acts as a global inhibitor of translation [4],
probably due to its direct interaction with ribosomes [5].
RelE might function in a similar manner in eukaryotic cells
and indeed a number of ribosome-inactivating proteins (RIPs)
are known which exhibit activity in both prokaryotic and
eukaryotic cells. However, RIPs, the majority of which are
derived from plants, are generally considerably more e¡ective
against eukaryotic ribosomes than their prokaryotic counter-
parts, typically by N-glycosidase activity on a conserved se-
quence in the 28S rRNA of the large subunit [13]. STX and its
relatives, from S. dysenteriae and certain strains of E. coli, are
the only bacterial RIPs which inhibit both prokaryotic and
eukaryotic translation machinery, apparently with equal ac-
tivity against both [9,14]. There are signi¢cant di¡erences be-
tween STX and RelE; however, for example, STX is a se-
creted type II RIP, composed of an A (active) chain, and a
B subunit which facilitates entry into the target cell, whereas
RelE forms part of an intracellular toxin^antitoxin module
with RelB. STX A chain acts catalytically to irreversibly in-
activate ribosomes, whereas RelE action seems to be revers-
ible if RelB is present [15]. The mode of action of RelE seems
likely to be unusual or unique, therefore, and deserves further
investigation.
One common feature of RelE and RIP action is the induc-
Fig. 3. Agarose gel of RT-PCR samples after 10, 20 and 30 cycles.
Template mRNA from the following cells was used: untreated (a)
and tetracycline-treated (b) U-relE cells; untreated (c) and tetracy-
cline-treated (d) U-Eler cells. M is a 100 bp ladder.
Fig. 4. DNA fragmentation assay showing genomic DNA from
U-relE and U-Eler cells treated with tetracycline (+T), actinomycin
D (+A) or untreated (C). M is a 100 bp ladder.
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tion of apoptosis. This endogenous cellular process operates
via at least two pathways, and is characterised by chromatin
condensation and degradation, membrane budding, cell vol-
ume reduction and nuclear matrix solubilisation leading to
cell death [11]. RIPs are known to induce mammalian cell
death by apoptosis [16^20]. The mechanism which triggers
apoptosis is currently unclear, but is apparently downstream
of 28S rRNA cleavage and inhibition of protein synthesis in
the case of K-sarcin. Inhibition of protein synthesis per se
using cycloheximide does not induce apoptosis, however
[20]. Although RelE might inhibit translation in mammalian
cells, it is unlikely to be a RIP (see above), suggesting that
investigation of its e¡ect on eukaryotic ribosomes will provide
further insight into triggering of apoptotic pathways.
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